Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Receives Average Rating of “Moderate Buy” from Analysts

by · The Cerbat Gem

Acadia Healthcare Company, Inc. (NASDAQ:ACHCGet Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the eight brokerages that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $91.22.

A number of research analysts have issued reports on ACHC shares. Royal Bank of Canada restated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Monday, March 4th. TD Cowen upped their target price on shares of Acadia Healthcare from $86.00 to $101.00 and gave the company an “outperform” rating in a report on Friday, March 1st. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday. Barclays initiated coverage on shares of Acadia Healthcare in a report on Wednesday. They issued an “overweight” rating and a $100.00 target price on the stock. Finally, Stephens upgraded shares of Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price objective on the stock in a report on Friday, January 5th.

Read Our Latest Report on Acadia Healthcare

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $81.81 on Friday. Acadia Healthcare has a 52 week low of $66.49 and a 52 week high of $87.77. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 0.48. The firm’s 50-day simple moving average is $82.85 and its 200 day simple moving average is $76.89. The firm has a market capitalization of $7.55 billion, a PE ratio of -327.23, a P/E/G ratio of 2.49 and a beta of 1.33.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.80 by $0.05. The business had revenue of $742.80 million for the quarter, compared to analyst estimates of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.70 EPS. On average, equities research analysts predict that Acadia Healthcare will post 3.56 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the sale, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, Director Debra K. Osteen sold 8,000 shares of the stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $76.23, for a total transaction of $609,840.00. Following the completion of the sale, the director now owns 710,833 shares of the company’s stock, valued at approximately $54,186,799.59. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Wade D. Miquelon sold 2,203 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now directly owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company’s stock.

Institutional Trading of Acadia Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Viking Global Investors LP grew its position in Acadia Healthcare by 24.2% in the fourth quarter. Viking Global Investors LP now owns 2,800,350 shares of the company’s stock valued at $217,755,000 after acquiring an additional 545,137 shares in the last quarter. William Blair Investment Management LLC boosted its position in Acadia Healthcare by 19.8% during the 2nd quarter. William Blair Investment Management LLC now owns 3,048,854 shares of the company’s stock worth $242,811,000 after acquiring an additional 504,572 shares during the period. Durable Capital Partners LP boosted its position in Acadia Healthcare by 30.8% during the 4th quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock worth $159,832,000 after acquiring an additional 457,687 shares during the period. Avidity Partners Management LP boosted its position in Acadia Healthcare by 61.8% during the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after acquiring an additional 441,692 shares during the period. Finally, Macquarie Group Ltd. boosted its position in Acadia Healthcare by 826.5% during the 1st quarter. Macquarie Group Ltd. now owns 493,486 shares of the company’s stock worth $35,654,000 after acquiring an additional 440,221 shares during the period.

Acadia Healthcare Company Profile

(Get Free Report

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Featured Stories